Back to results
US 2018/0264107 A1Published application
Treatment of autoimmune diseases
AssigneesGenentech, Inc., Biogen, Inc.
InventorsJohn G. Curd, Antonio J. Grillo-Lopez, Lori A. Kunkel
Life of this patent
Estimating the term…
Abstract
The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.
Claims24
A method of treating an autoimmune disease in a mammal comprising administering to the mammal a therapeutically effective amount of an antagonist which binds to a B cell surface marker.
Dependencies are inferred from the claim text.